Data / Form D filings / Altrartis Therapeutics Inc.
Altrartis Therapeutics Inc.: Form D filing
Altrartis Therapeutics Inc., a company in New York, NY, filed a Form D with the SEC in 2026. The latest, on October 22, 2026, reports $11 million sold of a $11 million offering to 11 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 228 PARK AVE S # 505778, New York, NY, 10003
- Phone
- 49 211 87973990185
- Industry
- Other
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2025
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2157050
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 22 | New notice | $10,999,977 | $10,999,977 | 11 | Aug 12 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Florian Brand | Executive Officer, Director, Promoter | |
| Lars Christian Wilde | Director |
Other companies in New York that filed recently
- SG QC Investment, LLC $20.7 million · Oct 22
- SG QC Holdings, LLC $31.8 million · Oct 22
- Axe Topco, Inc. offering · Oct 22
- MOG DEVELOPMENT Ltd LIABILITY Co offering · Oct 21
- Carter Investment Holdings, L.P. $111.8 million · Oct 21
- Kite Topco Inc. $5 million · Oct 21
Every Form D from the week of Oct 19 · All recent filings in New York · All recent Other filings
Read from SEC EDGAR. Amount sold is what Altrartis Therapeutics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.